OP0182 SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CO...
OP0182 SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TitAIN TRIAL
About this item
Full title
OP0182 SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TitAIN TRIAL
Author / Creator
Venhoff, N. , Schmidt, W.A. , Bergner, R. , Rech, J. , Unger, L. , Tony, H.P. , Mendelson, M. , Sieder, C. , Maricos, M. and Thiel, J.
Journal title
Annals of the rheumatic diseases, 2022-06, Vol.81, p.121-122
Language
English
Formats
More information
Alternative Titles
Full title
OP0182 SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TitAIN TRIAL
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_citationtrail_10_1136_annrheumdis_2022_eular_806
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1136_annrheumdis_2022_eular_806
Other Identifiers
ISSN
0003-4967
DOI
10.1136/annrheumdis-2022-eular.806
How to access this item
Log in as a Library member
